Adverum Biotechnologies
ADVM
ADVM
141 hedge funds and large institutions have $1.69B invested in Adverum Biotechnologies in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 60 increasing their positions, 38 reducing their positions, and 14 closing their positions.
Holders
141
Holders Change
+15
Holders Change %
+11.9%
% of All Funds
2.9%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.16%
New
29
Increased
60
Reduced
38
Closed
14
Calls
$15.9M
Puts
$5.1M
Net Calls
+$10.8M
Net Calls Change
-$273K
Top Buyers
| 1 |
1
Wellington Management Group
Boston,
Massachusetts
|
$25.9M |
| 2 |
2
BlackRock
New York
|
$123M |
| 3 |
CC
3
Casdin Capital
New York
|
$38.9M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$80.3M |
| 5 |
RCM
5
RA Capital Management
Boston,
Massachusetts
|
$163M |
Top Sellers
| 1 |
1
Victory Capital Management
San Antonio,
Texas
|
$2.73M |
| 2 |
2
Adage Capital Partners
Boston,
Massachusetts
|
$10.4M |
| 3 |
DM
3
Deerfield Management
New York
|
$17.4M |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$34.7M |
| 5 |
5
Renaissance Technologies
New York
|
$12.2M |
